7月3日，阿里健康盘中上涨3.49%，报3.28港元，成交额9192.81万港元，延续前一交易日涨势。
消息面上，6月29日恒瑞医药1类创新药瑞鸣及扬子江药业1类新药泰妥妥同日在阿里健康全网首发，强化了公司作为"新特药首发阵地"的平台定位。两款重磅创新药集中选择阿里健康作为线上独家首发渠道，验证了公司在创新药商业化环节的渠道价值与数字化服务能力。此前管理层已明确2027财年收入同比增长10%至15%的指引，创新药品类为核心增长驱动。同期京东健康涨5.27%、平安好医生涨5.23%，医药电商板块整体走强。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.